Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,000001 USD | -.--% | -.--% | -.--% |
2014 | Transcript : DiagnoCure Inc., Q4 2013 Earnings Call, Jan 16, 2014 | |
2013 | Transcript : DiagnoCure Inc., Q3 2013 Earnings Call, Sep 04, 2013 |
Omzet 2014 | 553K 402K 376K | Omzet 2015 | 515K 375K 350K | Marktkapitalisatie | 3,87 mln. 2,82 mln. 2,63 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2014 | -2 mln. -1,45 mln. -1,36 mln. | Nettowinst (verlies) 2015 | -3 mln. -2,18 mln. -2,04 mln. | EV/omzet 2014 | 4,15 x |
Nettoliquiditeiten 2014 | 2,17 mln. 1,58 mln. 1,48 mln. | Nettoliquiditeiten 2015 | 1,09 mln. 793K 741K | EV/omzet 2015 | 5,4 x |
K/w-verhouding 2014 |
-2,2
x | K/w-verhouding 2015 |
-1,08
x | Werknemers | - |
Dividendrendement 2014 * |
-
| Dividendrendement 2015 |
-
| Vrij verhandelbaar | 71,59% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yves Fradet
FOU | Founder | 73 | 08-12-94 |
Danielle Allard
SEC | Corporate Secretary | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yves Fradet
FOU | Founder | 73 | 08-12-94 |
Jacques Simoneau
CHM | Chairman | 66 | - |
Louise Proulx
IND | Independent Dir/Board Member | 73 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 43 | |
+1,28% | 42,86 mld. | |
+11,60% | 42,74 mld. | |
+45,21% | 41,36 mld. | |
-8,83% | 27,68 mld. | |
+7,72% | 25,15 mld. | |
-23,26% | 18,63 mld. | |
+29,69% | 12,37 mld. | |
-2,27% | 11,92 mld. | |
+7,57% | 11,21 mld. |